Skip to main content
AAN.com
Brief Communications
November 13, 2006
Letter to the Editor

CSF opening pressure: Reference interval and the effect of body mass index

November 14, 2006 issue
67 (9) 1690-1691

Abstract

We prospectively recorded CSF opening pressure in 242 adults who had a lumbar puncture with concomitant measurement of weight and height. The 95% reference interval for lumbar CSF opening pressure was 10 to 25 cm CSF. Body mass index had a small but clinically insignificant influence on CSF opening pressure.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
Daroff RB, Bradley WG, Marsden C. Neurology in clinical practice. Boston: Butterworth-Heinemann (Elsevier), 2004.
2.
Warrell DA, Cox TM, Cox JD, Benz EJ, eds. Oxford textbook of medicine. Oxford, UK: Oxford University Press, 2005.
3.
Corbett JJ, Mehta MP. Cerebrospinal fluid pressure in normal obese subjects and patients with pseudotumour cerebri. Neurology 1983;33:1386–1388.
4.
Gilland O, Tourtellotte WW, O’Tauma L, Henderson WG. Normal cerebrospinal fluid pressure. J Neurosurg 1974;40:587–593.
5.
Bono F, Lupo MR, Serra P. Obesity does not induce abnormal CSF pressure in subjects with normal cerebral MR venography. Neurology 2002;59:1641–1643.
Letters to the Editor
14 January 2007
CSF opening pressure: Reference interval and the effect of body mass index
Francesco Bono, MD, Institute of Neurology, University Magna Græcia
Aldo Quattrone, MD
We read with great interest the article by Whiteley et al. [1] The authors confirm our previous study showing that body mass index did not influence significantly CSF opening pressure. [2] Their data also indicate that 95 % reference interval for lumbar CSF pressure was 10 cm to 25 cm CSF, suggesting that increased intracranial pressure (ICP) should be diagnosed with caution in patients with CSF pressure less than 25 cm CSF. This interpretation of the data may not be appropriate.

Our major criticism is the exclusion criteria utilized in the study by Whiteley et al. The syndrome of increased ICP is not always associated with either persistent daily headache or papilledema, and no direct correlation exists between the degree of CSF pressure elevation and the presence of headache. Moreover, the headache profile of idiopathic intracranial hypertension (IIH) may be indistinguishable from that of migraine. [3,4]

In the study by Whiteley et al, only patients with papilledema, persistent daily headaches, tinnitus, or mass lesions on brain imaging were excluded while the authors included 9% of subjects with headache. This contrasts with reports that IIH may occur without papilledema, and it may be associated with both recurrent headache mimicking migraine and visual symtoms such as diplopia or transient visual obscuration. In addition, it is not clear how the authors excluded papilledema. Simple ophthalmoscopy with an ophthalmoscopy may not be sensitive enough to diagnose papilledema.

Furthermore, the authors did not characterize potential confounders such as factors that can increase ICP. It is well known that sinovenous stenosis, as revealed by MR venography, is strongly associated with increased ICP. [4,5] Sinovenous stenosis, however, was not investigated in the study by Whiteley et al. Another question is the presence in their series of 33% of patients with neuroinflammatory disorders often associated with CSF abnormalities, such as elevated levels of protein which can increase CSF pressure. Finally, the use of drugs potentially increasing CSF pressure should be carefully considered in investigating the reference interval for CSF pressure.

Taken together, these observations suggest that the reference interval for CSF pressure found by Whiteley et al must be accepted with caution. We are concerned that a misinterpretation of the data could transform clinical practice in neurologic centers. This will stall a line of research on IIH with or without papilledema that may yet revolutionize our understanding of increased ICP disorders.

References

1. Whitheley W, Al-Shahi R, Warlow CP, et al. CSF opening pressure: Reference interval and the effect of body mass index. Neurology 2006; 67;1690-1691.

2. Bono F, Lupo MR, Lucisano A, et al. Obesity does not induce abnormal CSF pressure in subjects with normal MR venography. Neurology 2002;59:1641 -1643.

3. Mathew NT, Ravishankar K, Sanin LC. Coexistence of migraine and idiopathic intracranial hypertension without papilledema. Neurology 1996;46:1226-1230.

4. Bono F, Messina D, Giliberto C, et al. Bilateral transverse sinus stenosis predicts IIH without papilledema in patients with migraine. Neurology 2006;67:419-423.

5. Bono F, Lupo MR, Lavano A, et al. Cerebral MR venography of transverse sinuses in subjects with normal CSF pressure. Neurology 2003;61:1267-1270.

Disclosure: The authors report no conflicts of interest.

14 January 2007
Reply from the Authors
William N. Whiteley, University of Edinburgh
Rustam Al-Shahi Salman, Christian Lueck and Charles Warlow

The purpose of our study was to provide a robust reference interval for CSF opening pressure for clinical neurologists. Our exclusion criteria – patients with papilloedema, persistent daily headache, tinnitus, mass lesions on brain imaging and headache characteristic of spontaneous intracranial hypotension - left us with patients where most practicing neurologists would not consider treatment which aimed to reduce CSF pressure.

In this study, the reference interval of patients with neuroinflammatory disorders was not significantly different from the overall estimate. Papilloedema was diagnosed by ophthalmoscopy by an experienced clinician with slit lamp examination in cases of doubt.

Patients with the syndrome of idiopathic intracranial hypertension without papilloedema (IIHWOP) are unlikely to have been included in this study. The interval for patients with any complaint of headache was not significantly different from the overall result and showed no evidence of a skewed distribution. The definition of the syndrome of IIHWOP is problematic because the diagnosis relies on the measurement of CSF pressure; it cannot be reliably diagnosed clinically.

As few patients with CSF pressures over 20cm CSF in our study had headache, we maintain that with current knowledge, the diagnosis of IIHWOP should be made with extreme caution, if at all, where CSF opening pressure is less than 25cm CSF and in some patients CSF pressures of up to 28cm CSF may be normal.

Disclosure: The authors report no conflicts of interest.

Information & Authors

Information

Published In

Neurology®
Volume 67Number 9November 14, 2006
Pages: 1690-1691
PubMed: 17101909

Publication History

Published online: November 13, 2006
Published in print: November 14, 2006

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

W. Whiteley, MRCP
From the Division of Clinical Neurosciences, University of Edinburgh, UK (W.W., R.A.-S., C.P.W., M.Z.); and The Canberra Hospital and the Australian National University, Canberra, Australia (C.J.L.).
R. Al-Shahi, MA, PhD, MRCP
From the Division of Clinical Neurosciences, University of Edinburgh, UK (W.W., R.A.-S., C.P.W., M.Z.); and The Canberra Hospital and the Australian National University, Canberra, Australia (C.J.L.).
C. P. Warlow, MD, FRCP
From the Division of Clinical Neurosciences, University of Edinburgh, UK (W.W., R.A.-S., C.P.W., M.Z.); and The Canberra Hospital and the Australian National University, Canberra, Australia (C.J.L.).
M. Zeidler, DM, FRCP
From the Division of Clinical Neurosciences, University of Edinburgh, UK (W.W., R.A.-S., C.P.W., M.Z.); and The Canberra Hospital and the Australian National University, Canberra, Australia (C.J.L.).
C. J. Lueck, PhD, FRCP
From the Division of Clinical Neurosciences, University of Edinburgh, UK (W.W., R.A.-S., C.P.W., M.Z.); and The Canberra Hospital and the Australian National University, Canberra, Australia (C.J.L.).

Notes

Address correspondence and reprint requests to Dr. William Whiteley, Bramwell Dott Building, Division of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, EH4 2XU, UK; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Syndrome of pseudotumor cerebri, Russian neurological journal, 29, 2, (43-54), (2024).https://doi.org/10.30629/2658-7947-2024-29-2-43-54
    Crossref
  2. Intracranial pressure following surgery of an unruptured intracranial aneurysm—a model for normal intracranial pressure in humans, Fluids and Barriers of the CNS, 21, 1, (2024).https://doi.org/10.1186/s12987-024-00549-1
    Crossref
  3. Idiopathic intracranial hypertension in Asians: a retrospective dual-center study, The Journal of Headache and Pain, 25, 1, (2024).https://doi.org/10.1186/s10194-024-01852-w
    Crossref
  4. Blood–CSF barrier integrity in amyotrophic lateral sclerosis, Brain, (2024).https://doi.org/10.1093/brain/awae144
    Crossref
  5. Radiological signs supporting idiopathic intracranial hypertension in symptomatic patients with lumbar puncture opening pressure < 250 mm, Scientific Reports, 14, 1, (2024).https://doi.org/10.1038/s41598-024-70588-z
    Crossref
  6. Cerebrospinal Fluid Pressure Measurement and Infusion Studies Using Lumbar Puncture, Neuroimaging Clinics of North America, (2024).https://doi.org/10.1016/j.nic.2024.08.002
    Crossref
  7. The Pseudotumor Cerebri Syndrome, Neurologic Clinics, 42, 2, (433-471), (2024).https://doi.org/10.1016/j.ncl.2024.02.001
    Crossref
  8. Non-Invasive Intracranial Pressure Monitoring, Journal of Clinical Medicine, 12, 6, (2209), (2023).https://doi.org/10.3390/jcm12062209
    Crossref
  9. A Neuro-Ophthalmologist’s Guide to Advances in Intracranial Pressure Measurements, Eye and Brain, Volume 15, (113-124), (2023).https://doi.org/10.2147/EB.S404642
    Crossref
  10. Lumbalpunktion – Schritt für Schritt, Intensivmedizin up2date, 19, 01, (10-16), (2023).https://doi.org/10.1055/a-1984-4050
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share